Oncology Patient-Reported Outcomes Tool May Lead To Comparative Tolerability Claims
This article was originally published in SRA
Executive Summary
A new patient-reported outcomes instrument for assessing toxicities in oncology trials ultimately could create an opportunity for comparative tolerability claims across cancer treatments.